< Back to previous page
Researcher
Patrik Verstreken
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Patrik Verstreken (Flanders Institute for Biotechnology)
Affiliations
- Research Group Molecular Neurobiology (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Responsible
From1 Jan 2008 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Member
From1 Jan 2017 → Today - VIB-KU Leuven Center for Brain & Disease Research (Research Center)
Responsible
From1 Jan 2017 → Today - Verstreken Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → 31 Dec 2016
Projects
1 - 10 of 54
- The Role of Parkinsonism genes in synaptic autophagyFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Tau-dependent synaptic remodeling in health and diseaseFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Translational Markers for Precision Medicine in Modifying Parkinson's DiseaseFrom1 Feb 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Investigating cell type specific defects in protein quality control across the genetic landscape of Parkinson’s diseaseFrom1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
- When size matters: a platform to study molecular interactions and multimerisationFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Dissecting the genetic interactions controlling α-Synuclein accumulation in Parkinson’s DiseaseFrom15 Mar 2022 → TodayFunding: FWO fellowships
- Analyzing the regulation of synaptic vesicle mobility by pre-synaptic liquid phase-separation in health and diseaseFrom7 Mar 2022 → TodayFunding: FWO fellowships
- Therapeutic targeting of pathogenic presynaptic Tau in human neurons in a chimeric Alzheimer’s Disease mouse modelFrom24 Jan 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Investigating cell type specific defects in protein quality control across the genetic landscape of Parkinson’s disease.From1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Resilience and vulnerability in the cellular phase of Alzheimer’s disease.From1 Oct 2021 → TodayFunding: BOF - Methusalem
Publications
121 - 130 of 146
- Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins(2011)
Authors: Valerie Uytterhoeven, Jaroslaw Kasprowicz, Patrik Verstreken
Pages: 117 - 132 - FlAsH-FALI Inactivation of a Protein at the Third-Instar Neuromuscular Junction(2011)
Authors: Patrik Verstreken
Pages: pdb.prot55 - Construction and Expression of Tetracysteine-Tagged Proteins for FlAsH-FALI(2011)
Authors: Patrik Verstreken
Pages: pdb.prot55 - Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease(2010)
Authors: Melissa Vos, Elsa Lauwers, Patrik Verstreken
Pages: 1 - 10 - Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease(2010)
Authors: Melissa Vos, Elsa Lauwers, Patrik Verstreken
Pages: 1 - 10 - Wiscott-Aldrich Syndrome Protein is activated by PI(4,5)P2 to restrict neuromuscular junction growth in a pathway parallel to BMP signaling(2010)
Authors: Thang Khuong Manh, Ron Habets, Jan Slabbaert, Patrik Verstreken
Pages: 17379 - 17384 - LRRK2, a Gene Mutated in Parkinson's Disease, Promotes Synaptic Vesicle Endocytosis(2010)
Authors: Samer Matta, Vanessa Morais, Wim Mandemakers, Sven Vilain, Bart De Strooper, Patrik Verstreken
Pages: S631 - S632 - Wiscott-Aldrich Syndrome Protein is activated by PI(4,5)P2 to restrict neuromuscular junction growth in a pathway parallel to BMP signaling(2010)
Authors: Thang Khuong Manh, Jan Slabbaert, Patrik Verstreken
Pages: 17379 - 17384 - Impaired Autonomic Regulation of Resistance Arteries in Mice With Low Vascular Endothelial Growth Factor or Upon Vascular Endothelial Growth Factor Trap Delivery(2010)
Authors: Erik Storkebaum, Max Mazzone, Koen Poesen, Diether Lambrechts, Patrik Verstreken, Peter Carmeliet
Pages: 273 - 281 - Neurologic Dysfunction and Male Infertility in Drosophila porin Mutants A NEW MODEL FOR MITOCHONDRIAL DYSFUNCTION AND DISEASE(2010)
Authors: Patrik Verstreken
Pages: 11143 - 11153
Patents
1 - 10 of 10
- Screening method for synaptogyrin-3 inhibitors (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)